| Project/Area Number |
18591613
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Cerebral neurosurgery
|
|---|
| Research Institution | Nihon University |
|---|
Principal Investigator |
KANO Tsuneo Nihon University, School of Medicine, Associate Professor (40277413)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
KATAYAMA Yoichi Nihon University, School of Medicine, Professor (00125048)
|
|---|
| Project Period (FY) |
2006 – 2007
|
| Project Status |
Completed (Fiscal Year 2007)
|
| Budget Amount *help |
¥3,650,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥450,000)
Fiscal Year 2007: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2006: ¥1,700,000 (Direct Cost: ¥1,700,000)
|
|---|
| Keywords | fibrinolysis / neurotoxicity / tissue plasminogen activator / ischemic stroke / neurotoxicity / edaravone |
|---|
| Research Abstract |
Objective and Methods : Deleterious effects of tissue plasminogen activator (tPA) have been described recently in experimental studies. For example, tPA can aggravate ischemic neuronal damage through its proteolytic activity. The present study was undertaken to examine whether or not the free radical scavenger, edaravone, could prevent the extravasation of tPA administered for the purpose of fibrinolysis in a rat model of thromboembolic stroke.
Results : Significant amounts of tPA were extravasated through the cerebral vessels even when early recanalization was induced by administering tPA at 30 minutes after the onset of schema. Edaravone significantly attenuated such extravasation of tPA.
Conclusion : In acute ischemic stroke patients, combination therapy using tPA with edaravone appears to be a re asonable strategy for diminishing the negative effects of tPA.
|
